Exicure to Present at the Cowen 40th Annual Healthcare Conference
March 02 2020 - 7:00AM
Business Wire
Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and
immunotherapeutic drugs utilizing spherical nucleic acid (SNA™)
technology, today announced that its chief executive officer, David
Giljohann, will give a company update on Wednesday, March 4, 2020
at 11:20 AM ET at the Cowen 40th Annual Healthcare Conference in
Boston.
Presentation and Breakout Session Details:
Cowen 40th Annual Health Care Conference Date: Wednesday, March
4, 2020 Presentation Time: 11:20-11:50 AM Eastern Time
A live audio webcast will be available on the Investors section
of Exicure’s website: www.exicuretx.com. The webcast will be
archived for approximately 30 days following the event.
About Exicure, Inc.
Exicure, Inc. is a clinical-stage biotechnology company
developing therapeutics for immuno-oncology, inflammatory diseases
and genetic disorders based on our proprietary Spherical Nucleic
Acid, or SNA technology. Exicure believes that its proprietary SNA
architecture has distinct chemical and biological properties that
may provide advantages over other nucleic acid therapeutics and may
have therapeutic potential to target diseases not typically
addressed with other nucleic acid therapeutics. Exicure's lead
program is in a Phase 1b/2 trial in patients with advanced solid
tumors. Exicure is based outside of Chicago, IL and in Cambridge,
MA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200302005191/en/
MacDougall Karen Sharma 781-235-3060 ksharma@macbiocom.com
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Jul 2023 to Jul 2024